Invitamos a los profesionales de la salud y a los medios especializados en salud a seguir de cerca esta revolucin en el tratamiento de la diabetes tipo 2
Were thrilled to be sharing new data from the proof-of-concept clinical study of NG101, our oral candidate to reduce nausea and vomiting induced by GLP-1 agonists
However, suddenly stopping the medication can still lead to uncomfortable side effects, such as headache, nausea, dizziness, or fatigue
Japan GLP-1 Supplement Market The Japan GLP-1 supplement market was estimated to be USD 72.34 million in 2025, supported by rising metabolic-health awareness among aging consumers and strong preference for portion-controlled nutrition products
Practical Steps to Manage Irritability During GLP-1 Treatment If you experience irritability in the first weeks of semaglutide therapy, first assess your sleep, hydration, and meal timing
Legal Compliance : Verify that the supplier complies with local regulations to avoid legal complications and ensure product integrity